Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)

GSK Investigational Site, Taichung

GSK Investigational Site, Berlin

GSK Investigational Site, Berlin

GSK Investigational Site, Erie

GSK Investigational Site, Columbia

GSK Investigational Site, Salisbury

GSK Investigational Site, Miami

GSK Investigational Site, Nashville

GSK Investigational Site, Lexington

GSK Investigational Site, Mainz

GSK Investigational Site, Frankfurt am Main

GSK Investigational Site, Newton

GSK Investigational Site, Tübingen

GSK Investigational Site, Pantelimon

GSK Investigational Site, Haag

GSK Investigational Site, Chandler

GSK Investigational Site, Augsburg

GSK Investigational Site, Las Vegas

GSK Investigational Site, Ploieşti

GSK Investigational Site, Guro Gu

GSK Investigational Site, Brasov

GSK Investigational Site, Galati

GSK Investigational Site, Galati

GSK Investigational Site, Brăila

GSK Investigational Site, Milford

GSK Investigational Site, Finsterwalde

GSK Investigational Site, Dresden

GSK Investigational Site, Dresden

GSK Investigational Site, Dresden

GSK Investigational Site, Freiberg

GSK Investigational Site, Bucharest

GSK Investigational Site, Bucharest

GSK Investigational Site, Bucharest

GSK Investigational Site, Gyeonggi-do

GSK Investigational Site, Incheon

GSK Investigational Site, Seoul

GSK Investigational Site, Balenyà (Barcelona)

GSK Investigational Site, Barcelona

GSK Investigational Site, Centelles

GSK Investigational Site, Taipei

GSK Investigational Site, La Roca Del Valles (Barcelona)

GSK Investigational Site, Vic/ Barcelona